Page last updated: 2024-12-05

n-butylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

n-butylamine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

butan-1-amine : A primary aliphatic amine that is butane substituted by an amino group at position 1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8007
CHEMBL ID13968
CHEBI ID43799
MeSH IDM0101332

Synonyms (93)

Synonym
STL308736
butylamine ,
1-aminobutane
1-butanamine
mono-n-butylamine
n-butylamine
nsc8029
1-aminobutan
wln: z4
nsc-8029
n-butylamin
norvalamine
109-73-9
1-amino-butaan
monobutylamine
1-butanaminen-butilamina
butylamine, n
CHEBI:43799 ,
butanamine
n-c4h9nh2
1-butylamine
butan-1-amine
1-amino-butane
inchi=1/c4h11n/c1-2-3-4-5/h2-5h2,1h
nsc 8029
ccris 4756
1-amino-butaan [dutch]
monobutilamina [romanian]
ai3-24197
fema no. 3130
1-aminobutan [german]
n-butilamina [italian]
hsdb 515
einecs 203-699-2
n-butylamin [german]
un1125
fema number 3130
butylamine, >=99%
butylamine, 99.5%
DB03659
NCIOPEN2_009229
B0707
AKOS000118810
CHEMBL13968
NCGC00248302-01
n-butilamina
ec 203-699-2
unii-n2qv60b4wr
n2qv60b4wr ,
monobutilamina
n-butylamine [un1125] [flammable liquid]
cas-109-73-9
tox21_301131
NCGC00255030-01
dtxcid501904
dtxsid1021904 ,
FT-0623326
BBL027788
n-butylamine [mi]
n-butylamine [hsdb]
butylamine [mart.]
butylamine [fhfi]
butylamine, n-
normal-butyl amine
butane-1-amine
n-butan-1-amine
butyl amine
nbunh2
butylarnine
n-butyl-amine
n-bunh2
n-butyiamine
bunh2
n-butyl amine
un 1125
norralamine
mfcd00011690
J-002322
F2190-0358
butylamine, analytical reference material
butylamine, 99%
butylamine, purum, >=98.0% (gc)
butylamine, purum, >=99.0% (gc)
butylamine, puriss., >=99.5% (gc)
butylamine, puriss., 99.0%
1-butanamine, 9ci
aminobutane
fema 3130
Q421035
BP-30251
AMY21914
STR01992
EN300-19577

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Compounds with hydroxy groups oriented ortho or para to one another are more toxic than predicted by this equation, and the toxicity trends within this group of compounds are rationalized in terms of the electrophilic chemistry of their oxidation products."( Chemistry-toxicity relationships for the effects of di- and trihydroxybenzenes to Tetrahymena pyriformis.
Aptula, AO; Cronin, MT; Roberts, DW; Schultz, TW, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
primary aliphatic amine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency0.20610.000229.305416,493.5996AID743075
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency11.58760.001024.504861.6448AID743215
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.20610.023723.228263.5986AID743223
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (26)

Assay IDTitleYearJournalArticle
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID350219Lipophilicity, log K at pH 2 by by hydrophilic interaction chromatography using 95% acetonitrile as mobile phase2009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
AID23253Partition coefficient (logP) (carbon tetrachloride)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID23255Partition coefficient (logP) (ether)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID279547Antiproliferative activity against Leishmania donovani DI700 promastigotes overproducing ODC enzyme2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Leishmania donovani polyamine biosynthetic enzyme overproducers as tools to investigate the mode of action of cytotoxic polyamine analogs.
AID279549Antiproliferative activity against Leishmania donovani DI700 promastigotes overproducing ADOMETDC enzyme2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Leishmania donovani polyamine biosynthetic enzyme overproducers as tools to investigate the mode of action of cytotoxic polyamine analogs.
AID23252Partition coefficient (logP) (benzene)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID342464Dissociation constant, pKa of the compound2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
The many roles for fluorine in medicinal chemistry.
AID350216Dissociation constant, pKa of the compound2009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
AID23254Partition coefficient (logP) (chloroform)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1471796Reactivation of cyclosarin inhibited human erythrocyte AChE assessed as residual activity at 10 to 1000 uM using acetylthiocholine iodide as substrate preincubated for 2 to 120 mins followed by substrate addition measured for 3 mins by Ellman's method2017Journal of medicinal chemistry, 11-22, Volume: 60, Issue:22
Application of the Ugi Multicomponent Reaction in the Synthesis of Reactivators of Nerve Agent Inhibited Acetylcholinesterase.
AID279551Antiproliferative activity against Leishmania donovani DI700 promastigotes in presence of 100 uM spermidine2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Leishmania donovani polyamine biosynthetic enzyme overproducers as tools to investigate the mode of action of cytotoxic polyamine analogs.
AID279548Antiproliferative activity against Leishmania donovani DI700 promastigotes overproducing SPDSYN enzyme2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Leishmania donovani polyamine biosynthetic enzyme overproducers as tools to investigate the mode of action of cytotoxic polyamine analogs.
AID1651246Drug metabolism in THF assessed as release of hydrogen disulphide at 10 mM in presence of S-acetylsulfanylethanethioate by DSP-3 probe based fluorescence assay2020Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4
Diacyl disulfides as the precursors for hydrogen persulfide (H
AID350220Lipophilicity, log K at pH 2 by by hydrophilic interaction chromatography using 100% water as mobile phase2009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
AID279550Antiproliferative activity against Leishmania donovani DI700 promastigotes in presence of 100 uM putrescine2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Leishmania donovani polyamine biosynthetic enzyme overproducers as tools to investigate the mode of action of cytotoxic polyamine analogs.
AID1471798Reactivation of tabun inhibited human erythrocyte AChE assessed as residual activity at 10 to 1000 uM using acetylthiocholine iodide as substrate preincubated for 2 to 120 mins followed by substrate addition measured for 3 mins by Ellman's method2017Journal of medicinal chemistry, 11-22, Volume: 60, Issue:22
Application of the Ugi Multicomponent Reaction in the Synthesis of Reactivators of Nerve Agent Inhibited Acetylcholinesterase.
AID279546Antiproliferative activity against Leishmania donovani DI700 promastigotes2007Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2
Leishmania donovani polyamine biosynthetic enzyme overproducers as tools to investigate the mode of action of cytotoxic polyamine analogs.
AID350218Octanol-water partition coefficient, log PC of the compound2009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
AID23251Partition coefficient (logP)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID23256Partition coefficient (logP) (hexane)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID227946Decarboxylation of oxaloacetate to produce pyruvate was measured bythe conversion of NADH to NAD+ in the lactate dehydrogenase mediated transformation of pyruvate to lactate; expressed as Catalytic efficiency as the ratio of (kcat/KM)2001Bioorganic & medicinal chemistry letters, Oct-08, Volume: 11, Issue:19
Design, synthesis and characterisation of a peptide with oxaloacetate decarboxylase activity.
AID781327pKa (acid-base dissociation constant) as determined by Morgenthaler ref: ChemMedChem 20072014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (82)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (21.95)18.7374
1990's11 (13.41)18.2507
2000's22 (26.83)29.6817
2010's24 (29.27)24.3611
2020's7 (8.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 70.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index70.06 (24.57)
Research Supply Index4.47 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index118.30 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (70.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other86 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]